Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2006 September;31(3) > Minerva Endocrinologica 2006 September;31(3):211-8

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA ENDOCRINOLOGICA

A Journal on Endocrine System Diseases


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,383


eTOC

 

ORIGINAL ARTICLES  


Minerva Endocrinologica 2006 September;31(3):211-8

Copyright © 2006 EDIZIONI MINERVA MEDICA

language: English

Growth hormone provocation tests and their prediction in the growth of children treated for acute lymphoblastic leucemia

Papadia C. 1, 2, Naves L. A. 2, Motta L. D. C. 3, Barboza Filho R. F. 1, 2, Suzuki M. T. 1, Casulari L. A. 1, 2

1 Department of Neurosurgery Hospital de Base do Distrito Federal Brasília, Brazil 2 Endocrinology Department University of Brasília, Brasília, Brazil 3 Gynecology and Obstetric Department University of Brasília, Brasília, Brazil


PDF  


Aim. The aim of this study was to evaluate the positive predictive value of two growth hormone stimulation tests (insulin-induced hypoglycemia and clonidine) for stature below percentile 10 in patients treated for acute lymphoblastic leukemia in childhood.
Methods. The study population was a cohort of 30 patients (aged 14.1±2.9 years; 20 male) treated for acute lymphoblastic leukemia during childhood and then examined after insulin-induced hypoglycemia (30 patients) and clonidine (16 patients) tests. The follow-up time was 7.7±2.8 years since treatment and 2.3±1.3 years after administration of the tests.
Results. In the last evaluation, 12 patients (40%) were below and 18 (60%) were above percentile 10. The insulin-induced hypoglycemia test response was: 9 patients (30%) had growth hormone peak <5 ng/mL and 19 (63.3%) <7 ng/mL. The clonidine test response was: 7 patients had growth hormone peak <5 ng/mL and 8 (50%) <7 ng/mL. For stature below of the percentile 10, the positive predictive values of insulin-induced hypoglycemia test (33%) and clonidine (28%) were low when growth hormone peak <5 ng/mL was considered; however, when growth hormone peak <7 ng/mL was considered, the positive predictive values were 83% and 50% for the insulin-induced hypoglycemia and clonidine tests, respectively.
Conclusion. In patients treated for acute lymphoblastic leukemia in childhood, the positive predictive values for statural deficit of both tests were low, except for the insulin-induced hypoglycemia test when a growth hormone peak <7 ng/mL was considered.

top of page

Publication History

Cite this article as

Corresponding author e-mail